About Cytox
Cytox is a company based in Oxford (United Kingdom) founded in 2007. Cytox has raised $12.13 million across 8 funding rounds from investors including Gov.uk, Maven Capital Partners and Future Planet Capital Regional. The company has 12 employees as of January 31, 2021. Cytox operates in a competitive market with competitors including Strand Life Sciences, Invitae, Genome Medical, Myriad Genetics and Fulgent Genetics, among others.
- Headquarter Oxford, United Kingdom
- Employees 12 as on 31 Jan, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cytox Limited
- Date of Incorporation 09 Jun, 2004
- Jurisdiction MANCHESTER
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$12.13 M (USD)
in 8 rounds
-
Latest Funding Round
Not available
-
Investors
Gov.uk
& 14 more
-
Employee Count
12
as on Jan 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Cytox
Unlock access to complete
Unlock access to complete
Funding Insights of Cytox
Cytox has successfully raised a total of $12.13M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cytox
Cytox has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include Gov.uk, Maven Capital Partners and Future Planet Capital Regional.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are targeted for private equity investments.
|
Locked | Locked | Locked | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Investment solutions are provided by Catapult Ventures for growth.
|
Locked | Locked | Locked |
Investor details for Cytox
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cytox
Investment portfolio details for Cytox
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cytox
Detailed financials for Cytox
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cytox Comparisons
Peer comparison for Cytox
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cytox
Cytox operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Strand Life Sciences, Invitae, Genome Medical, Myriad Genetics and Fulgent Genetics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Home-based genetic tests for detecting diseases are provided to individuals.
|
|
| Locked | Locked | Locked |
Genomic testing services are provided clinically and directly to consumers.
|
|
| Locked | Locked | Locked |
Molecular diagnostics and personalized medicine for cancer are developed.
|
|
| Locked | Locked | Locked |
Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer
|
|
| Locked | Locked | Locked |
High-throughput gene sequencing platform is developed for clinical diagnostics.
|
Detailed competitors of Cytox
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cytox
Complete news archive for Cytox
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytox
Cytox was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Cytox is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Cytox is a funded company, having raised a total of $12.13M across 8 funding rounds to date.
As of Jan 31, 2021, the latest employee count at Cytox is 12.
Cytox was founded in 2007 in Oxford, United Kingdom, within the biotechnology sector focused on diagnostics. SNP targets in the mTOR pathway are investigated to predict and diagnose mild cognitive impairment, recognized as an early stage of dementia and Alzheimers disease. Diagnostic approaches are provided through two products, genoSCORE LAB and genoTOR, which employ blood and saliva samples for risk assessment.
Cytox's top competitors include Strand Life Sciences, Fulgent Genetics and Centogene.
Cytox has 15 investors. Key investors include Gov.uk, Maven Capital Partners, Future Planet Capital Regional, European Union, and Oxford University Innovation.